Salasar Techno Engineering Ltd: Intrinsic Value & Share Price Analysis

Last Updated: December 13, 2025, 8:51 am

All Competitor Stocks of Salasar Techno Engineering Ltd

Last Updated: August 20, 2025, 4:10 am

Below is a detailed analysis of the quarterly data for Salasar Techno Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 300.17 Cr.. The value appears to be declining and may need further review. It has decreased from 483.31 Cr. (Mar 2025) to 300.17 Cr., marking a decrease of 183.14 Cr..
• For Expenses, as of Jun 2025, the value is 270.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 455.86 Cr. (Mar 2025) to 270.23 Cr., marking a decrease of 185.63 Cr..
• For Operating Profit, as of Jun 2025, the value is 29.94 Cr.. The value appears strong and on an upward trend. It has increased from 27.45 Cr. (Mar 2025) to 29.94 Cr., marking an increase of 2.49 Cr..
• For OPM %, as of Jun 2025, the value is 9.97%. The value appears strong and on an upward trend. It has increased from 5.68% (Mar 2025) to 9.97%, marking an increase of 4.29%.
• For Other Income, as of Jun 2025, the value is 1.64 Cr.. The value appears strong and on an upward trend. It has increased from -3.91 Cr. (Mar 2025) to 1.64 Cr., marking an increase of 5.55 Cr..
• For Interest, as of Jun 2025, the value is 13.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.86 Cr. (Mar 2025) to 13.76 Cr., marking a decrease of 0.10 Cr..
• For Depreciation, as of Jun 2025, the value is 6.05 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.74 Cr. (Mar 2025) to 6.05 Cr., marking an increase of 1.31 Cr..
• For Profit before tax, as of Jun 2025, the value is 11.77 Cr.. The value appears strong and on an upward trend. It has increased from 4.94 Cr. (Mar 2025) to 11.77 Cr., marking an increase of 6.83 Cr..
• For Tax %, as of Jun 2025, the value is 25.23%. The value appears to be improving (decreasing) as expected. It has decreased from 206.07% (Mar 2025) to 25.23%, marking a decrease of 180.84%.
• For Net Profit, as of Jun 2025, the value is 8.79 Cr.. The value appears strong and on an upward trend. It has increased from -5.23 Cr. (Mar 2025) to 8.79 Cr., marking an increase of 14.02 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.05. The value appears strong and on an upward trend. It has increased from -0.03 (Mar 2025) to 0.05, marking an increase of 0.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: October 15, 2025, 4:31 am

Last Updated: September 5, 2025, 1:20 pm

Last Updated: December 10, 2025, 3:21 am

Below is a detailed analysis of the balance sheet data for Salasar Techno Engineering Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 173.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 173.00 Cr..
• For Reserves, as of Sep 2025, the value is 640.00 Cr.. The value appears strong and on an upward trend. It has increased from 613.00 Cr. (Mar 2025) to 640.00 Cr., marking an increase of 27.00 Cr..
• For Borrowings, as of Sep 2025, the value is 350.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 317.00 Cr. (Mar 2025) to 350.00 Cr., marking an increase of 33.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 686.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 622.00 Cr. (Mar 2025) to 686.00 Cr., marking an increase of 64.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,848.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,725.00 Cr. (Mar 2025) to 1,848.00 Cr., marking an increase of 123.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 397.00 Cr.. The value appears strong and on an upward trend. It has increased from 394.00 Cr. (Mar 2025) to 397.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,446.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,330.00 Cr. (Mar 2025) to 1,446.00 Cr., marking an increase of 116.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,848.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,725.00 Cr. (Mar 2025) to 1,848.00 Cr., marking an increase of 123.00 Cr..

Notably, the Reserves (640.00 Cr.) exceed the Borrowings (350.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Salasar Techno Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.34 (Mar 24) to 0.11, marking a decrease of 0.23.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.34 (Mar 24) to 0.11, marking a decrease of 0.23.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 3. It has decreased from 0.40 (Mar 24) to 0.22, marking a decrease of 0.18.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.55. It has increased from 2.86 (Mar 24) to 4.55, marking an increase of 1.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.55. It has increased from 2.86 (Mar 24) to 4.55, marking an increase of 1.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 8.38. It has increased from 7.66 (Mar 24) to 8.38, marking an increase of 0.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 2. It has decreased from 0.79 (Mar 24) to 0.69, marking a decrease of 0.10.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.73 (Mar 24) to 0.58, marking a decrease of 0.15.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.45 (Mar 24) to 0.22, marking a decrease of 0.23.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 2. It has decreased from 0.33 (Mar 24) to 0.11, marking a decrease of 0.22.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 2. It has decreased from 0.33 (Mar 24) to 0.11, marking a decrease of 0.22.
• For PBDIT Margin (%), as of Mar 25, the value is 8.27. This value is below the healthy minimum of 10. It has decreased from 10.41 (Mar 24) to 8.27, marking a decrease of 2.14.
• For PBIT Margin (%), as of Mar 25, the value is 6.93. This value is below the healthy minimum of 10. It has decreased from 9.57 (Mar 24) to 6.93, marking a decrease of 2.64.
• For PBT Margin (%), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 10. It has decreased from 5.96 (Mar 24) to 2.73, marking a decrease of 3.23.
• For Net Profit Margin (%), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 5. It has decreased from 4.38 (Mar 24) to 1.32, marking a decrease of 3.06.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 8. It has decreased from 4.38 (Mar 24) to 1.31, marking a decrease of 3.07.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 15. It has decreased from 11.75 (Mar 24) to 2.43, marking a decrease of 9.32.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.08. This value is within the healthy range. It has decreased from 23.03 (Mar 24) to 12.08, marking a decrease of 10.95.
• For Return On Assets (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has decreased from 4.59 (Mar 24) to 1.10, marking a decrease of 3.49.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.02, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.77 (Mar 24) to 0.40, marking a decrease of 0.37.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.17 (Mar 24) to 1.01, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has increased from 1.35 (Mar 24) to 1.42, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 1.04, marking an increase of 0.22.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.46. This value is below the healthy minimum of 4. It has increased from 2.69 (Mar 24) to 3.46, marking an increase of 0.77.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 3. It has decreased from 2.88 (Mar 24) to 2.31, marking a decrease of 0.57.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.54. This value is below the healthy minimum of 3. It has decreased from 2.21 (Mar 24) to 1.54, marking a decrease of 0.67.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,688.19. It has decreased from 3,478.42 (Mar 24) to 1,688.19, marking a decrease of 1,790.23.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 1.17, marking a decrease of 1.71.
• For EV / EBITDA (X), as of Mar 25, the value is 14.09. This value is within the healthy range. It has decreased from 27.63 (Mar 24) to 14.09, marking a decrease of 13.54.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 2.61 (Mar 24) to 0.98, marking a decrease of 1.63.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 1.81. This value is within the healthy range. It has decreased from 7.01 (Mar 24) to 1.81, marking a decrease of 5.20.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 2.61 (Mar 24) to 0.98, marking a decrease of 1.63.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks